Patent
Novel Ginsenoside Derivative Compounds And The Use Thereof In Protection Against Ischemia/Reperfusion Injury
Jing-Rong Wang,Pei Luo,Hua Zhou,Wai In Chan,Liang Liu,Zhi-Hong Jiang +5 more
- 23 Apr 2015
TL;DR: In this paper, the ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury are described. But they do not describe the use of ginsenide derivatives in medical applications.
read more
Abstract: The present invention provides novel ginsenoside derivative compounds and the use thereof in protection against ischemia/reperfusion injury.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
References
Saponins from Vietnamese Ginseng, Panax vietnamensis HA et GRUSHV. Collected in Central Vietnam. III
Nguyen Minh Duc,Ryoji Kasai,Kazuhiro Ohtani,Aiko Ito,Nguyen Thoi Nham,Kazuo Yamasaki,Osamu Tanaka +6 more
TL;DR: Five new dammarane saponins derived from four new aglycones were isolated from the rhizomes and roots of Panax vietnamensis Ha et Grushv on the basis of physicochemical and spectral evidence.
Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide
TL;DR: In this article, the authors investigated the role of natriuretic peptide receptor C (NPR-C) activation in the regulation of local blood flow and proposed a new regulatory pathway for coronary blood flow.
138
Bioactive Saponins and Glycosides. Part 29
TL;DR: In this paper, three acylated oleanane-type triterpene saponins, theasaponins A6 (1), A7 (2), and B5 (3), were isolated from the saponin fraction of the seeds of the Japanese tea plant Camellia sinensis together with the known constituent foliatheasaponin III.
136
Enzymatic Preparation of Ginsenosides Rg2, Rh1, and F1
TL;DR: This is the first report on the enzymatic preparation of minor saponins, ginsenosides Rg(2) and Rh(1), and of an intestinal bacterial metabolite, gINSenoside F(1, with high efficiency from a protopanaxatriol-type saponin mixture.
92